Welcome to our dedicated page for Inter & Co SEC filings (Ticker: INTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Inter & Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Inter & Co's regulatory disclosures and financial reporting.
Inter & Co. Inc. (INTR) filed a Form 144 disclosing a proposed sale of 89,000 Class A shares through HSBC Bank USA on 08/13/2025. The shares were acquired on 02/13/2023 as employee compensation under a Form S-8 and were exercised via a cashless exercise. The aggregate market value of the proposed sale is reported as $731,405.54 and the total shares outstanding are listed as 323,014,076. The filer reports no sales in the past three months and includes the standard representation that no undisclosed material adverse information is known.
Inter & Co. filed a Rule 144 notice reporting a proposed sale of 28,112 Class A shares, with an aggregate market value of $219,557.91. The shares were acquired on 06/23/2022 in a business combination transaction registered on Form F-4 by exchange of Banco Inter shares. The broker listed is Inter&Co Securities, LLC and the approximate sale date is 08/08/2025 on Nasdaq. No securities were reported sold in the past three months and the filer affirms no undisclosed material adverse information.